Study Finds Season of Entry Impacts Childhood Obesity Outcomes
A secondary analysis of New Zealand’s Whānau Pakari program examined 397 children aged 3.7‑16.8 years to determine whether the season of enrollment influences six‑month BMI outcomes. Overall, 68% reduced their BMI‑SD score by an average of 0.16, but spring entrants showed no significant change while those starting in autumn, winter or summer achieved meaningful reductions. Random‑forest modelling revealed that, after accounting for lifestyle shifts, season of entry became a stronger predictor of improvement than any single behavior. The study highlights how school‑holiday disruptions can undermine obesity‑intervention success.
US Pricing Reform Reshapes Drug Launch Strategies: Dee Chaudhary
U.S. drug‑pricing reforms, especially the Most Favored Nation (MFN) rule, are forcing manufacturers to align American prices with the lowest prices offered abroad. As a result, firms are pulling back from launches in France, Germany and the Nordic region to...
Scientists Uncover a Hidden Mechanism Cancer Cells Use to Rewrite Genetic Messages, Revealing a Promising New Target for Treatment
A team of molecular biologists has uncovered a previously unknown RNA‑binding protein that rewrites messenger‑RNA messages in cancer cells, effectively reprogramming gene expression. The discovery explains how tumors can rapidly adapt to hostile environments and develop resistance to standard chemotherapy....
How Age, Sex, and Cancer Type Shape the Risk of New Cancers in Survivors
A new epidemiological study of more than 1.2 million cancer survivors reveals that age, sex, and the original cancer type dramatically influence the likelihood of developing a second primary malignancy. Survivors over 65 face up to a 60% higher risk,...
Pasadena Clinic Received $34 Million in Medicare Skin Graft Scam, Court Documents Say
Federal prosecutors seized over $2 million from Expert Wound Care, a Pasadena clinic accused of billing Medicare $34 million for skin‑graft procedures that patients never received. The scheme involved 78 beneficiaries, with a single patient billed more than $6 million. Medicare’s spending on...
Medicare Won’t Cover It: 5 Common Health Expenses That May Blindside Retirees
Medicare leaves significant gaps that can surprise retirees, especially for routine dental, vision and hearing services that are largely excluded from Original Medicare. The most costly omission is long‑term care, with a 65‑year‑old needing roughly $135,000 to cover future expenses,...
New Clinical Guidelines Significantly Reduce Opioid Prescriptions After Ear Surgery
A retrospective analysis of more than 25,000 patients across 80 U.S. health systems shows that the American Academy of Otolaryngology‑Head and Neck Surgery Foundation’s opioid prescribing guideline, released in April 2021, immediately reduced postoperative opioid prescriptions after parotidectomy. Data from the...
VCU Study Identifies Key Factors Driving Risk of Second Cancers
Researchers at Virginia Commonwealth University examined data from more than 3 million U.S. cancer survivors spanning 1975‑2019, revealing that the likelihood of a second primary cancer depends heavily on age at initial diagnosis, sex, and the type of first cancer. Older...
How Price Transparency Could Fix the Abandoned Rx Issue: Laura Jensen
GoodRx’s chief commercial officer Laura Jensen argued that greater drug‑price transparency could dramatically cut the roughly one billion annual abandoned prescriptions in the United States. Speaking at Asembia’s AXS26 conference, she highlighted how transparent, consumer‑facing platforms can deliver easier‑to‑access discounts for...
New AI Models Quickly Find Compounds that Target Lyme Bacteria
Tufts University researchers have leveraged AI and machine‑learning to rapidly pinpoint narrow‑spectrum antibiotics that kill the Lyme disease bacterium Borrelia burgdorferi. Screening 60,000 existing compounds yielded several hundred hits, and generative models now explore an estimated 10^60 drug‑like molecules to...
Implant Trade Secrets Are Not Protectable Due to Disclosure in Patents
The Federal Circuit ruled that trade secrets disclosed in patents are unprotectable under the California Uniform Trade Secrets Act, reversing a district court decision in International Medical Devices, Inc. v. Cornell. The court found three of IMD’s alleged secrets “generally...
Advanced Gene Editing ‘Promising’ for Sickle Cell Disease
Two recent New England Journal of Medicine studies demonstrate that CRISPR‑Cas12a (reni‑cel) and base‑editing (risto‑cel) autologous stem‑cell therapies can dramatically raise fetal hemoglobin and normalize total hemoglobin in sickle cell patients. The RUBY trial reported a rise from 2.5% to...
Human-Centered Digital Transformation in Specialty Pharmacy
At the AXS26 Summit, AcariaHealth executives outlined a human‑centered digital transformation for specialty pharmacy that streamlines workflows while keeping personal clinician contact. They showcased a secure‑messaging onboarding process that trims a typical 45‑minute intake call to a brief exchange and...
FDA Debuts Plan to Collect Real-Time Clinical Trial Data
The U.S. Food and Drug Administration announced a pilot program that will collect clinical‑trial data in real time, allowing scientific reviewers to see information as it is generated. The initiative, launched on Tuesday, includes participation from major drugmakers AstraZeneca and...
How to Implement AI-Powered Coronary Plaque Analysis Software—And Ensure You Get Paid
Artificial intelligence is now being used to analyze coronary plaque in CT angiography, offering detailed, non‑invasive assessments of coronary artery disease. Medicare expanded coverage and introduced Category 1 CPT codes in 2024, allowing providers to be reimbursed for AI‑driven plaque analysis....
Aylward Enterprises Highlights Custom Packaging Automation Solutions for Complex Solid-Dose Applications
Aylward Enterprises showcased its Custom Packaging Automation portfolio, targeting complex oral solid‑dose (OSD) products such as quick‑dissolve capsules, softgels, and irregularly shaped tablets. Leveraging proprietary feeding, filling and robotic technologies, the company delivers integrated lines that move blisters to cartoners,...
Federated Machine Learning Gives Healthcare Organizations a Competitive AI Advantage
Federated machine learning lets health systems train AI models on‑site, sending only model updates to a central server. This decentralized approach preserves patient privacy while aggregating insights from multiple hospitals, such as Mayo Clinic and Vanderbilt University, using NVIDIA‑powered platforms....
GLP-1 Receptor Agonist Add-On at Immune Checkpoint Inhibitor Initiation and Fewer Wasting-Related Diagnoses and Acute-Care Episodes in People with Cancer...
A target‑trial emulation of US TriNetX data examined cancer patients with obesity who started immune checkpoint inhibitors (ICIs) and received a GLP‑1 receptor agonist (GLP‑1 RA) at initiation. After 1:1 propensity matching, 988 patients per arm were followed for up to...
Cutting Cancer Care Costs, Rethinking ACA Policy: Justin Favaro, MD
At the Institute for Value‑Based Medicine conference in Charlotte, oncologist Justin Favaro highlighted how independent oncology practices can dramatically lower chemotherapy costs and deliver care at roughly $1,000 per Medicare patient in annual savings. He noted that health‑care now accounts...
Trump Admin Revives COVID Origins Debate with Indictment
The Justice Department has indicted David Morens, a former senior adviser at the National Institute of Allergy and Infectious Diseases, on conspiracy and record‑tampering charges for allegedly deleting emails and routing communications to a personal account to hide information about...
Reproductive Health Service Utilization and Associated Factors Among Womens With Disabilities in Gedeo Zone, Southern Ethiopia: Cross-Sectional Study
A cross‑sectional study of 605 women with disabilities in Ethiopia’s Gedeo Zone found that only 15.7% accessed sexual and reproductive health (SRH) services in the past year. The majority were single, rural, and physically impaired, with 94.5% not using family‑planning...
Two Tiers Too Many. Re: Doctors’ Distinct Work and Professional Role Can’t Be Parcelled Into Generic Tasks for “Tiers” Of...
A BMJ letter from retired consultant psychiatrist David Bowker argues that the NHS’s push toward generic “tiers” of healthcare staff erodes the distinct professional role of doctors. He cites the experience of psychiatrists trained in the 1970s who later faced...
Pfizer Delays Patent Cliff for Blockbuster Vyndamax
Pfizer announced a two‑year extension of market exclusivity for Vyndamax (tafamidis), pushing the expected generic launch to 2026. The extension stems from a new formulation patent and a pediatric study that grant additional protection. Vyndamax, approved for transthyretin amyloid cardiomyopathy,...
Dual-Agonist Survodutide Shows Significant Weight Loss in Phase III Obesity Trial
Boehringer Ingelheim reported that its dual glucagon/GLP‑1 agonist survodutide produced up to 16.6% average weight loss after 76 weeks in the Phase III SYNCHRONIZE‑1 trial. The study also showed that 85.1% of treated participants achieved at least a 5% reduction, with...
Uveitis Attack History May Predict Cataract Surgery Outcomes
Researchers at Turkey's Uak Training and Research Hospital examined 54 eyes with uveitis‑associated cataracts that underwent phacoemulsification and intra‑ocular lens implantation. Each additional uveitis attack added roughly 1.29 days to postoperative topical steroid therapy and was modestly linked to poorer...
Hikma and Amarin's Generic Drug Case Heads to Supreme Court Arguments
The U.S. Supreme Court will hear arguments this week in the dispute between Hikma Pharmaceuticals and Amarin over a prescription‑strength fish‑oil pill, the first generic challenge to Amarin’s Vascepa. The case centers on whether the FDA’s bioequivalence standards and the...
BIOTECanada Responds to Health Canada’s Gazette on a Draft Order Providing for Reliance on International Regulatory Authorities
Health Canada’s Gazette released a draft Order that would allow Canadian regulators to rely on approvals from trusted foreign agencies, a key component of the Red Tape Review initiative. BIOTECanada praised the proposal, calling it a meaningful step toward faster...
PCI Benefits Stable Patients More in Focal vs Diffuse Disease: ORBITA-2
A new ORBITA‑2 sub‑analysis shows that patients with focal coronary disease experience markedly greater angina relief from PCI than those with diffuse disease. Using pressure‑wire iFR pullbacks, investigators found an odds ratio of 1.80 for symptom improvement and 1.55 for...
Diffusion MRI as A Biomarker for Monitoring Recovery After Surgical Repair of Traumatic Peripheral Nerve Injuries: A Longitudinal Case Series
A longitudinal case series evaluated diffusion tensor imaging (DTI) as a biomarker for monitoring recovery after surgical repair of severe ulnar and median nerve transections. Researchers tracked fractional anisotropy (FA) values alongside Medical Research Council sensory and motor grades for...
FDA Grants RMAT Status to Orca-Q in High-Risk Hematologic Malignancies
The U.S. Food and Drug Administration has awarded Regenerative Medicine Advanced Therapy (RMAT) designation to Orca‑Q, an investigational allogeneic T‑cell immunotherapy targeting high‑risk hematologic malignancies. The designation follows early phase 1 data that hint at improved overall survival, lower graft‑versus‑host disease...
Centene Hikes 2026 Profit Guidance After Buoyant Q1
Centene posted Q1 adjusted earnings of $3.37 per share, far surpassing analysts’ $2.25‑$2.30 expectations, driven by rate hikes that offset a 2‑million drop in ACA enrollment. Net profit rose 18% to $1.5 billion on revenue of $49.9 billion, prompting the company to...
Pfizer Deals Extend Patent Life for a Top-Selling Rare Disease Drug
Pfizer announced settlements with Dexcel Pharma, Hikma Pharmaceuticals and Cipla that push the patent expiry of its rare‑disease drug Vyndamax to June 1, 2031. The deals delay generic tafamidis entry, keeping U.S. sales stable through the early 2030s after the company warned...
U.S. Government Will Stop Paying for Test Strips to Detect Deadly Drugs
The Trump administration announced that SAMHSA will stop paying for fentanyl test strips, reversing a policy that began in 2021. The agency says the strips encourage drug use, prompting a letter to states and grant recipients. The change unsettles programs...
Asian American Communities Report Delaying Care Due to Cost, Recent Immigration Policies
A nationwide electronic survey of 1,027 Asian American, Native Hawaiian and Pacific Islander adults revealed major gaps in screening and treatment for hepatitis B, diabetes, and tuberculosis. While 90% reported a primary‑care physician, only 40% had been screened for hepatitis B and...
Restylane, Sculptra Combo Improves Skin Dryness, Collagen Loss for Menopausal Women
Interim data from two investigator‑initiated trials show that a sequential regimen of Restylane Skinboosters followed by Sculptra markedly improves skin hydration, firmness and collagen density in menopausal women. The 9‑month study reported peak patient satisfaction at month six, with measurable...
FDA Grants Clearance for Avatar Medical Vision
Avatar Medical has received FDA 510(k) clearance for its Avatar Medical Vision platform, enabling instant 3D processing of CT and MR images for surgical planning. The software supports glasses‑free 3D displays, virtual reality and integrates with Barco’s Eonis monitor, allowing...
Scientists May Have Finally Created a Male Birth Control Pill—So Far, It Shows Very Few Side Effects
YourChoice Therapeutics reported that its experimental male contraceptive pill YCT‑529 was well‑tolerated in a Phase 1 trial of 16 healthy, vasectomized men. The non‑hormonal compound halted sperm production without altering testosterone, heart rate, mood, or sexual desire. Pre‑clinical work in mice...
Frequency of Medical Liability Lawsuits Is Declining, but Risk Remains for Doctors: AMA
The American Medical Association’s latest Physician Practice Benchmark Survey shows that the proportion of doctors sued at least once dropped to 28.7% in 2024 from 31.2% in 2022, indicating a modest decline in medical‑liability lawsuits. However, litigation risk remains concentrated...
Iowa FD's Whole Blood Pilot Program Proves Worth with Stabbing Victim
The Des Moines Fire Department launched a pilot that equips ambulances with whole‑blood units and transfusion kits, allowing paramedics to start life‑saving transfusions before hospital arrival. In February, a paramedic used the system on a stabbing victim, delivering blood on...
5 Costly IP Mistakes to Avoid
The article outlines five costly intellectual‑property mistakes that medical‑device innovators frequently make, from relying on a single patent to neglecting global filings and broader brand protection. It stresses building a “picket fence” of patents that cover the core device, components,...
Mental Health Chatbots Raise Serious Ethical Concerns, Review Warns
A new peer‑reviewed study in Digital Health warns that mental‑health chatbots are outpacing ethical oversight. The authors identify four major risks: limited human involvement, a weak evidence base, extensive data‑privacy concerns, and the potential for undisclosed criminal activity. They argue...
STAT+: Supreme Court to Hear Case About ‘Skinny Labeling’ and Generic Access
The U.S. Supreme Court will hear oral arguments on a case involving “skinny labeling,” a practice where generic manufacturers seek approval to market a drug for only a subset of its approved uses. By limiting the label, generics aim to...
CEOs Face Congressional Hearing on High Hospital Prices
Four hospital CEOs testified before the House Ways and Means Committee about soaring hospital prices, which have risen roughly 300% over the past two decades. Committee Chair Jason Smith highlighted that 2,000 of the nation’s 4,500 hospitals have merged, giving...
ACA Market Dynamics Cost HCA $150M in Q1
HCA Healthcare posted a modest 0.6% rise in Q1 net income to $1.6 billion and a 4.3% revenue increase to $19.1 billion. A milder-than‑expected respiratory season slashed related admissions by 42% and ER visits by 32%, curbing volume growth. Storms disrupted markets...
Moderna Deploys Salesforce Agentforce Life Sciences to Unify Global Commercial Operations
Moderna has chosen Salesforce’s Agentforce Life Sciences platform to unify its global commercial operations. The solution will merge data from SAP, e‑commerce and regional systems into a single Customer 360 view, powered by IQVIA OneKey. AI‑driven agents will automate cycle planning,...
$739 Million Acquisition of XOMA Strengthens Ligand’s Biopharma Portfolio
Ligand Pharmaceuticals announced a $739 million acquisition of XOMA Royalty, expanding its royalty‑financing portfolio to over 200 assets. The deal adds more than 120 new royalty streams, including seven marketed drugs such as Vabysmo and Ojemda, and deepens exposure to oncology,...
Zimmer Biomet CFO Departs for New Job
Zimmer Biomet’s chief financial officer, Suketu Upadhyay, is leaving after seven years to become CFO of biotech firm Incyte. The orthopedics maker named controller Paul Stellato as interim CFO while it searches for a permanent replacement. In its first quarter,...
Rocket's PRV Goes for $180M; Oruka Targets $500M Offering
New Jersey‑based Rocket Pharmaceuticals sold its pediatric‑disease priority‑review voucher for $180 million, setting a near‑record price for such assets. The cash infusion strengthens Rocket’s balance sheet as it advances late‑stage gene‑therapy candidates. Meanwhile, biotech firm Oruka Therapeutics announced plans to raise...
Humanizing the Ultimate Balancing Act
The article argues that aligning radiology, IT, finance, and operations in healthcare requires treating stakeholders as humans, not adversaries. It highlights that each function has non‑negotiable priorities—quality and safety for radiology, security for IT, margin for finance, and throughput for...
Integrating a Waste Walk Into Technology Adoption: A Primer
Medical imaging leaders often adopt new scanners, AI tools or PACS without fully understanding the underlying workflow problems, leading to under‑utilization and missed KPI targets. A waste walk—rooted in Lean methodology—offers a low‑cost, observational approach that maps the entire value...